[{"address1": "8 Moore Drive", "city": "Durham", "state": "NC", "zip": "27709", "country": "United States", "phone": "877 495 0816", "website": "https://www.fortrea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 15500, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas H. Pike", "age": 65, "title": "CEO & Chairman", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 2191755, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jill  McConnell", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 735386, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Morais", "age": 47, "title": "COO & President of Clinical Services", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 732472, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Drayton  Virkler", "title": "President & Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Parks", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John J. Doyle M.D.", "title": "Chief Scientific Officer & President of Consulting Services", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alejandro Martinez Galindo", "title": "Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Cooper", "title": "Chief Administrative Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hima B. Inguva", "title": "Head of Investor Relations & Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J. Stillman Hanson J.D.", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.05, "open": 13.99, "dayLow": 13.48, "dayHigh": 14.35, "regularMarketPreviousClose": 14.05, "regularMarketOpen": 13.99, "regularMarketDayLow": 13.48, "regularMarketDayHigh": 14.35, "payoutRatio": 0.0, "forwardPE": 10.57252, "volume": 2328950, "regularMarketVolume": 2328950, "averageVolume": 1135783, "averageVolume10days": 910880, "averageDailyVolume10Day": 910880, "bid": 13.68, "ask": 13.94, "bidSize": 16, "askSize": 16, "marketCap": 1242345088, "fiftyTwoWeekLow": 13.48, "fiftyTwoWeekHigh": 41.02, "priceToSalesTrailing12Months": 0.41751078, "fiftyDayAverage": 17.259, "twoHundredDayAverage": 21.26515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2343845120, "profitMargins": -0.10082, "floatShares": 77743887, "sharesOutstanding": 89700000, "sharesShort": 7296116, "sharesShortPriorMonth": 5917472, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0813, "heldPercentInsiders": 0.00354, "heldPercentInstitutions": 1.05794, "shortRatio": 6.38, "shortPercentOfFloat": 0.1173, "impliedSharesOutstanding": 89759904, "bookValue": 16.873, "priceToBook": 0.8208381, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -217900000, "trailingEps": -2.44, "forwardEps": 1.31, "enterpriseToRevenue": 0.788, "enterpriseToEbitda": 86.489, "52WeekChange": -0.6171662, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 13.85, "targetHighPrice": 27.2, "targetLowPrice": 17.0, "targetMeanPrice": 22.2, "targetMedianPrice": 22.0, "recommendationKey": "none", "numberOfAnalystOpinions": 11, "totalCash": 105300000, "totalCashPerShare": 1.174, "ebitda": 27100000, "totalDebt": 1206800000, "quickRatio": 0.998, "currentRatio": 1.177, "totalRevenue": 2975600128, "debtToEquity": 79.736, "revenuePerShare": 33.34, "returnOnAssets": -0.01045, "returnOnEquity": -0.13586001, "grossProfits": 454900000, "freeCashflow": 368200000, "operatingCashflow": 263100000, "revenueGrowth": -0.055, "grossMargins": 0.15288, "ebitdaMargins": 0.00911, "operatingMargins": -0.01363, "financialCurrency": "USD", "symbol": "FTRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_1793665465", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "regularMarketChangePercent": -1.4234861, "regularMarketPrice": 13.85, "corporateActions": [], "postMarketTime": 1740784751, "regularMarketTime": 1740776402, "shortName": "Fortrea Holdings Inc.", "marketState": "CLOSED", "longName": "Fortrea Holdings Inc.", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1687267800000, "postMarketChangePercent": -0.000723002, "postMarketPrice": 13.8499, "postMarketChange": -0.000100136, "regularMarketChange": -0.19999981, "regularMarketDayRange": "13.48 - 14.35", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1135783, "fiftyTwoWeekLowChange": 0.37000084, "fiftyTwoWeekLowChangePercent": 0.027448134, "fiftyTwoWeekRange": "13.48 - 41.02", "fiftyTwoWeekHighChange": -27.17, "fiftyTwoWeekHighChangePercent": -0.66235983, "fiftyTwoWeekChangePercent": -61.71662, "earningsTimestamp": 1741008600, "earningsTimestampStart": 1741008600, "earningsTimestampEnd": 1741008600, "earningsCallTimestampStart": 1741010400, "earningsCallTimestampEnd": 1741010400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.44, "epsForward": 1.31, "epsCurrentYear": 0.51297, "priceEpsCurrentYear": 26.999632, "fiftyDayAverageChange": -3.4090004, "fiftyDayAverageChangePercent": -0.19752015, "twoHundredDayAverageChange": -7.4151497, "twoHundredDayAverageChangePercent": -0.34869963, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Clinical Development business of Laboratory Corporation of America Holdings", "nameChangeDate": "2025-02-28", "cryptoTradeable": false, "displayName": "Fortrea", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]